Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (DIVA): A Single Arm Clinical Trial
Phase of Trial: Phase I/II
Latest Information Update: 28 Nov 2018
At a glance
- Drugs Disulfiram (Primary) ; Vorinostat (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms DIVA
- 19 Nov 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated
- 06 Oct 2017 Status changed from recruiting to suspended.